Abstract
The intravenous Na-tolbutamide test was done on various types of hypoglyce-mia and the following conclusions were obtained: (1) Though very useful in the screening of hypoglycemia, the test is not always satisfactory for the differential diagnosis of various types of hypoglycemia. (2) The diagnosis of hypoglycemia by means of the Na-tolbutamide test is con-sidered practically established when the recovering ability from hypoglycemic levels is absent or insufficient, so as to give a value of the recovery index mostly 0.5 or less, and the stationary value is not higher than 55mg/100ml. (3) Pronounced hypoglycemia occasionally persists in some cases of functional hypoglycemia. Temporary rise in the blood sugar levels is observed in some cases of pancreatic hyperinsulinism. Differential diagnosis between the two types of hypoglycemia is impossible when only the Na-tolbutamide test is employed. (4) In a patient with diabetes complicated with hypoglycemia, the blood sugar level 20 and 30 minutes after intravenous tolbutamide injection showed an obvious decrease in the decline rate. (5) Biphasic fluctuations of blood sugar levels after intravenous tolbutamide injection were observed in three cases of hyperinsulinism.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
